Corcept Therapeutics
CORT
CORT
245 hedge funds and large institutions have $2.26B invested in Corcept Therapeutics in 2023 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 81 increasing their positions, 92 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 225 → 245 (+20)
0.15% more ownership
Funds ownership: 80.25% → 80.4% (+0.15%)
12% less repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 92
Holders
245
Holding in Top 10
4
Calls
$11.5M
Puts
$6.54M
Top Buyers
| 1 | +$22.4M | |
| 2 | +$13.9M | |
| 3 | +$10.9M | |
| 4 |
D.E. Shaw & Co
New York
|
+$10M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$9.43M |
Top Sellers
| 1 | -$29.1M | |
| 2 | -$13.7M | |
| 3 | -$5.86M | |
| 4 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
-$4.61M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$4.59M |